RNTX
Rein Therapeutics·NASDAQ
--
--(--)
--
--(--)
RNTX fundamentals
Rein Therapeutics (RNTX) released its earnings on Nov 14, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.21 (YoY +22.22%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.21
+22.22%
Report date
Nov 14, 2025
EPS
Actual | -4.8 | -2.8 | -2.6 | -2.4 | -1.6 | -1.2 | -1.4 | -1.6 | -1.8 | -1.8 | -1.4 | -0.4 | -1.54 | -0.86 | -0.45 | -0.27 | -1.89 | -0.25 | -0.28 | -0.21 | |||||||||
Forecast | -4.05 | -3.75 | -2.5 | -2.5486 | -1.35 | -1.4667 | -1.4 | -1.6 | -1.5333 | -1.7 | -1.65 | -0.4 | -0.2 | -0.1637 | -0.14 | -0.2256 | -0.245 | -0.3 | -0.21 | -0.22 | -0.24 | ||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -18.52% | +25.33% | -4.00% | +5.83% | -18.52% | +18.18% | 0.00% | 0.00% | -17.39% | -5.88% | +15.15% | 0.00% | -100.00% | -840.75% | -514.29% | -99.47% | -10.20% | -530.00% | -19.05% | -27.27% | +12.50% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
Did Rein Therapeutics beat or miss consensus estimates last quarter?What factors drove the changes in Rein Therapeutics's revenue and profit?What is Rein Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Rein Therapeutics’s earnings call?What is Rein Therapeutics's gross profit margin?What is the market's earnings forecast for Rein Therapeutics next quarter?What does Rein Therapeutics do and what are its main business segments?What were the key takeaways from Rein Therapeutics's earnings call?
